statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	332
IT - Italia	190
SG - Singapore	138
CN - Cina	65
BR - Brasile	46
HK - Hong Kong	36
VN - Vietnam	32
DE - Germania	25
FR - Francia	20
FI - Finlandia	18
GB - Regno Unito	18
BD - Bangladesh	17
IN - India	16
NL - Olanda	16
CA - Canada	14
RU - Federazione Russa	12
ID - Indonesia	9
PK - Pakistan	9
TR - Turchia	9
JP - Giappone	8
SE - Svezia	8
IQ - Iraq	6
AR - Argentina	5
PL - Polonia	4
ZA - Sudafrica	4
AT - Austria	3
AU - Australia	3
IE - Irlanda	3
UA - Ucraina	3
AE - Emirati Arabi Uniti	2
CL - Cile	2
EG - Egitto	2
ES - Italia	2
GR - Grecia	2
MX - Messico	2
MY - Malesia	2
OM - Oman	2
PE - Perù	2
RO - Romania	2
TH - Thailandia	2
AL - Albania	1
BE - Belgio	1
BN - Brunei Darussalam	1
BO - Bolivia	1
CH - Svizzera	1
CO - Colombia	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
FJ - Figi	1
GT - Guatemala	1
IR - Iran	1
JM - Giamaica	1
JO - Giordania	1
KG - Kirghizistan	1
KR - Corea	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
MM - Myanmar	1
MO - Macao, regione amministrativa speciale della Cina	1
MT - Malta	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
UY - Uruguay	1
Totale	1.115

Nome	#
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects	158
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo	155
Role of gremlin-1 in the pathophysiology of the adipose tissues	108
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells	104
Alternative method to visualize receptor dynamics in cell membranes	97
The D647N mutation of FGFR1 induces ligand-independent receptor activation	91
The Extracellular Matrix modulates mechanotransduction and metabolic alteration in EC leading to melanoma vascularization	85
Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics	85
The mechanics of anoikis resistance in cancer	82
Receptor tyrosine kinases alterations in cancer modulates mechano-properties and drug response in tumoral and endothelial cells	79
Lipid-Protein Interplay in the Regulation of Receptor Tyrosine Kinases	65
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling	21
Totale	1.130

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	58	1	3	1	6	12	4	5	5	8	1	3	9
2023/2024	88	7	3	8	9	10	4	4	2	4	6	9	22
2024/2025	318	27	2	8	39	23	22	43	18	37	23	53	23
2025/2026	666	47	48	23	67	76	50	97	50	51	88	50	19
Totale													1.130